Found: 132
Select item for more details and to access through your institution.
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network.
- Published in:
- Liver International, 2024, v. 44, n. 9, p. 2442, doi. 10.1111/liv.16006
- By:
- Publication type:
- Article
Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B A Systematic Review.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 1, p. 63, doi. 10.1007/s40273-012-0009-2
- By:
- Publication type:
- Article
Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0208036
- By:
- Publication type:
- Article
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hepatitis E Virus Epidemiology in Industrialized Countries.
- Published in:
- Emerging Infectious Diseases, 2003, v. 9, n. 4, p. 448, doi. 10.3201/eid0904.020351
- By:
- Publication type:
- Article
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 1, p. 32, doi. 10.1093/cid/civ722
- By:
- Publication type:
- Article
Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 8, p. 1064, doi. 10.1093/cid/ciu066
- By:
- Publication type:
- Article
In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17185, doi. 10.3390/ijms242417185
- By:
- Publication type:
- Article
Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14654, doi. 10.3390/ijms232314654
- By:
- Publication type:
- Article
Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 706, doi. 10.1111/liv.15814
- By:
- Publication type:
- Article
Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2611, doi. 10.1111/liv.15776
- By:
- Publication type:
- Article
Securing wider EU commitment to the elimination of hepatitis C virus.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 276, doi. 10.1111/liv.15446
- By:
- Publication type:
- Article
Pilot hepatitis C micro‐elimination strategy in Pakistani migrants in Catalonia through a community intervention.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 1751, doi. 10.1111/liv.15327
- By:
- Publication type:
- Article
Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1922, doi. 10.1111/liv.14877
- By:
- Publication type:
- Article
Nucleos(t)ide analogue therapy: The role of tenofovir alafenamide.
- Published in:
- Liver International, 2021, v. 41, p. 9, doi. 10.1111/liv.14848
- By:
- Publication type:
- Article
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries.
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 934, doi. 10.1111/liv.14808
- By:
- Publication type:
- Article
Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 1906, doi. 10.1111/liv.14489
- By:
- Publication type:
- Article
Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues.
- Published in:
- Liver International, 2020, v. 40, p. 15, doi. 10.1111/liv.14367
- By:
- Publication type:
- Article
Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1868, doi. 10.1111/liv.14155
- By:
- Publication type:
- Article
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1940, doi. 10.1111/liv.13858
- By:
- Publication type:
- Article
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg‐positive chronic hepatitis B.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1760, doi. 10.1111/liv.13716
- By:
- Publication type:
- Article
Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network (HDIN).
- Published in:
- Liver International, 2018, v. 38, n. 5, p. 842, doi. 10.1111/liv.13604
- By:
- Publication type:
- Article
Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B.
- Published in:
- Liver International, 2018, v. 38, p. 84, doi. 10.1111/liv.13641
- By:
- Publication type:
- Article
Long-term efficacy and safety of nucleos(t) ides analogues in patients with chronic hepatitis B.
- Published in:
- Therapeutic Advances in Infectious Disease, 2021, v. 8, p. 1, doi. 10.1177/2049936120985954
- By:
- Publication type:
- Article
Drugs in Development for Hepatitis B.
- Published in:
- Drugs, 2005, v. 65, n. 11, p. 1451, doi. 10.2165/00003495-200565110-00001
- By:
- Publication type:
- Article
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant.
- Published in:
- Infection & Drug Resistance, 2018, v. 11, p. 2207, doi. 10.2147/IDR.S172226
- By:
- Publication type:
- Article
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.
- Published in:
- Infection & Drug Resistance, 2010, v. 3, p. 133, doi. 10.2147/IDR.S7136
- By:
- Publication type:
- Article
Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence.
- Published in:
- Revista Española de Quimioterapia, 2020, v. 33, n. 4, p. 1, doi. 10.37201/req/030.2020
- By:
- Publication type:
- Article
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study.
- Published in:
- Revista Española de Quimioterapia, 2015, v. 28, n. 3, p. 145
- By:
- Publication type:
- Article
Isolation of Campylobacter fetus Subspecies fetus from a Gluteal Abscess.
- Published in:
- Clinical Infectious Diseases, 1994, v. 19, n. 3, p. 557
- By:
- Publication type:
- Article
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.
- Published in:
- 2018
- By:
- Publication type:
- case study
Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report.
- Published in:
- 2017
- By:
- Publication type:
- case study
Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence Conservation.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5481, doi. 10.3390/ijms25105481
- By:
- Publication type:
- Article
Serological diagnosis of acute delta hepatitis.
- Published in:
- Journal of Medical Virology, 1986, v. 18, n. 1, p. 81, doi. 10.1002/jmv.1890180110
- By:
- Publication type:
- Article
The elimination of hepatitis D as a public health problem: Needs and challenges.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 1, p. 47, doi. 10.1111/jvh.13891
- By:
- Publication type:
- Article
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 335, doi. 10.1111/jvh.13800
- By:
- Publication type:
- Article
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 1015, doi. 10.1111/jvh.13741
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 579, doi. 10.1111/jvh.13686
- By:
- Publication type:
- Article
Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 3, p. 227, doi. 10.1111/jvh.13634
- By:
- Publication type:
- Article
Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1319, doi. 10.1111/jvh.13497
- By:
- Publication type:
- Article
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 8, p. 1177, doi. 10.1111/jvh.13545
- By:
- Publication type:
- Article
Unexpected long‐lasting anti‐HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 7, p. 747, doi. 10.1111/jvh.13285
- By:
- Publication type:
- Article
Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1127, doi. 10.1111/jvh.13132
- By:
- Publication type:
- Article
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 7, p. 865, doi. 10.1111/apt.17898
- By:
- Publication type:
- Article
Editorial: Liver elastography for chronic hepatitis D—the end of liver biopsy?
- Published in:
- 2024
- By:
- Publication type:
- Editorial